Building negative incentives into value-based insurance design programs to discourage use of low-value care will involve a number of challenges.
Dan Greenberg, PhD
Advertisement
Articles by Dan Greenberg, PhD
A systematic literature review from 1998 to 2003 showed that few cost-effectiveness analyses of self-administered medications model suboptimal medication adherence.
Advertisement
Latest Updated Articles
- Do Drug Formulary Policies Reflect Evidence of Value?
January 1st 2006
- Low-Value Services in Value-Based Insurance Design
April 7th 2010
- Patient Adherence: A Blind Spot in Cost-Effectiveness Analyses?
September 7th 2009
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%
3
Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care
4
FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies
5